Pharmaceutical Sub-sector Research Articles

PENGARUH RASIO AKTIVITAS DENGAN PERHITUNGAN PERPUTARAN KAS, PERPUTARAN PIUTANG, DAN PERPUTARAN PERSEDIAAN TERHADAP PROFITABILITAS PADA PERUSAHAAN SUB SEKTOR FARMASI DI BURSA EFEK INDONESIA PERIODE TAHUN 2014-2023

The pharmaceutical industry is a crucial sector in Indonesia's economy. The profitability of pharmaceutical companies is key to their sustainability and business development. One of the factors that influences profitability is the efficiency of company asset management, which can be measured from cash turnover, receivables turnover and inventory turnover. The aim of this research is to determine and analyze the effect of cash turnover, accounts receivable turnover and inventory turnover on profitability in Pharmaceutical Sub-Sector Companies Listed on the Indonesia Stock Exchange in 2014-2023. The data used in this research consists of secondary data from financial statements for the years 2014-2023. This research used purposive sampling to obtain a sample of 6 companies. The analysis technique in this research uses descriptive analysis, panel data regression analysis, classical assumption testing, and hypotheses. The research results show that partially the cash turnover and receivables turnover variables do not have a significant effect on profitability, while receivables turnover has a significant effect on profitability. simultaneously the variables cash turnover, accounts receivable turnover and inventory turnover have a significant effect on profitability.

THE IMPACT OF CASH TURNOVER, INVENTORY TURNOVER, AND RECEIVABLES TURNOVER ON PROFITABILITY IN PHARMACEUTICAL SUB-SECTOR COMPANIES LISTED ON THE INDONESIA STOCK EXCHANGE FOR THE PERIOD 2019-2023

The profitability of a company refers to its ability to generate net profit from activities conducted during an accounting period. Profit reflects the performance achieved from transactions undertaken by the company over a specific period. Stakeholders use profit as an indicator to assess the effectiveness of management in running the company. One sub-sector that plays an important role in the national economy is the pharmaceutical sub-sector. The pharmaceutical industry is one of the mainstay sectors that plays a major role in the main movement in the future. This subsector's investment development isn't always fascinating, according to the Investment Coordinating Board (BKPM). Variations in profit income or profitability were observed between 2019 and 2023, as per the yearly report study. Finding out how the variables of cash turnover, inventory turnover, and accounts receivable turnover affect profitability is the main goal of this study. Sampling in this study was done by purposive sampling technique, which is a sampling technique based on certain criteria so that a sample of 11 Pharmaceutical Sub-Sector Companies was obtained. The analysis technique used was multiple linear regression using the SPSS Version 11 analysis tool. The results showed that cash turnover had a positive and insignificant effect on profitability, inventory turnover had a negative and insignificant effect on profitability and receivables turnover had a positive and significant effect on profitability.

Pengaruh Corporate Social Responsibility (CSR) terhadap Kinerja Keuangan Perusahaan pada Sub Sektor Industri Farmasi yang Terdaftar di Bursa Efek Indonesia Periode 2019-2023

This study is entitled The Effect of Corporate Social Responsibillity (CSR) on the Company's Financial Performance in the Pharmaceutical Sub-Sector for the 2019-2023 Period. The purpose of this study is first to determine the effect of Corporate Social Responsibillity (CSR) on Return On Assets (ROA). Second, to determine the effect of Corporate Social Responsibillity (CSR) on Return On Equity (ROE). Third, to determine the effect of Corporate Social Responsibillity (CSR) on Gross Profit Margin (GPM). Fourth, to determine the effect of Corporate Social Responsibillity (CSR) on Nett Profit Margin (NPM). The research method used is quantitative, this type of research data is secondary data using a simple regression equation model. The results showed that CSR has no effect on ROA with a significant value of 0.193 greater than 0.05, CSR has no effect on ROE with a significant value of 0.568 greater than 0.05, CSR has no effect on GPM with a significance value of 0.059 greater than 0.05, and CSR has no effect on NPM with a significance value of 0.451 greater than 0.05, which means that companies that are active in CSR activities do not always tend to have better financial performance. CSR is one of the company's strategies to improve its image and reputation, which is expected to contribute to improved financial performance.

Pengaruh Ukuran Perusahaan, Opini Audit, Profitabilitas, dan Audit Tenure Terhadap Audit Report lag pada Perusahaan Barang dan Konsumsi Sub Sektor Farmasi yang Terdaftar di BEI Tahun 2016-2022

This study aims to analyze the influence of Company Size, Audit Opinion, Profitability, and Audit Tenure on Audit Report Lag in the pharmaceutical subsector consumer goods and consumer goods industry listed on the Indonesia Stock Exchange in 2016-2022. Company size is measured by Total Assets, Audit Opinion with Dummy, Profitability with Return On Assets (ROA), Audit Tenure with Total Years of Engagement. The research population consisted of 11 companies listed on the Indonesian Stock Exchange. A sample of 72 companies was selected using the saturated sample method. The results of data analysis show that simultaneously Company Size, Audit Opinion, Profitability, Audit Tenure have a significant effect on Audit Report Lag. Partially, company size has no effect on Audit Report Lag, indicating that large and small company sizes have the ability to pressure their auditors to complete audit work on time and are not a determining factor in Audit Report Lag, Audit Opinion has a partially negative effect on Audit Report Lag, shows that companies that receive an unqualified opinion from the auditor for their financial reports will tend to urge the auditor to immediately complete the audit report because an unqualified opinion is good news from the auditor. Profitability has a partial negative effect on Audit Report Lag, indicating that if a company produces a higher level of profitability, the Audit Report Lag will be shorter. Audit Tenure has a partial positive effect on Audit Report Lag, indicating that the longer the engagement between the client and the Auditor, the longer the Audit Report Lag will be.

Fundamental Analysis of Stock Price Changes in Pharmaceutical Subsector Companies Listed on the Indonesia Stock Exchange for the Period 2016 – 2020

The aim of this research is to analyse the impact of Return On Assets (ROA), Return On Equity (ROE), and Earnings Per Share (EPS) on the stock prices of pharmaceutical companies listed on the Indonesia Stock Exchange. This study employs a quantitative approach. The data used are secondary data in the form of company financial reports obtained from the Indonesia Stock Exchange (IDX). The sample selection in this study used purposive sampling, which involves selecting samples based on specific criteria. The data analysis method applied is multiple linear regression analysis. The results of this study indicate that the independent variable ROE positively correlates with stock price prediction, as evidenced by a calculated t-value of 5.721, which is greater than the critical t-value of 2.02619. EPS also positively correlates with stock price prediction, with a calculated t-value of 2.004, which is slightly less than the critical t-value of 2.02619. However, the ROA variable negatively correlates with stock price prediction, with a calculated t-value of -4.273, which is less than the critical t-value of 2.02619. Return On Assets (ROA), Return On Equity (ROE), and Earnings Per Share (EPS) collectively have a significant impact on stock prices. From the regression coefficient test, it is concluded that 56% of the stock price can be explained by the independent variables. This study illustrates that the pharmaceutical subsector companies listed on the Indonesia Stock Exchange rely more on a strong capital structure to improve financial performance, with a focus on increasing stock prices.

The Role of Product Development Costs in Moderate Managerial Ownership Seen From The Indicators of Return on Asset, Cash Ratio, and Total Asset Turnover

This research aims to determine the effect of Return on Assets, Cash Ratio, Total Assets Turnover to Managerial Ownership with Product Development Costs as a Moderating Variable. This research uses the Pharmaceutical subsector company objects on the Indonesia and Malaysia Stock Exchanges for the 2013-2021 period. The data collected is secondary data with a documentation method in the form of the company's annual report. The analytical tool used to test the hypothesis is IBM SPSS V21. The sampling method used in this research used a purposive sampling technique to obtain 10 companies that presented complete financial reports, resulting in 90 samples. The analysis technique used is descriptive statistical analysis, classical assumption test, moderated regression analysis (MRA), multiple linear regression, t test, and f test. The research results partially concluded that Return on Assets and Cash Ratio influences managerial ownership while Total Assets Turnover has no effect on Managerial Ownership. The results of the research simultaneously show a calculated f value of 3.099 and an f table of 2.71, meaning calculated f > f table or a significance value of 0.031 <0.05. So Return on Assets, Cash Ratio, and Total Assets Turnover has a simultaneous effect on Managerial Ownership. Research results Moderated Regression Analysis (MRA) shows that Product Development Costs can moderate the Return relationship on Assets to Managerial Ownership and Product Development Costs can moderate the Cash relationship Ratio to Managerial Ownership. Meanwhile, Product Development Costs cannot moderate the Total Asset relationship Turnover on Managerial Ownership. For further research, it is hoped that it will examine other sub-sectors and add other variables.

Factors Affecting Cash Holding in Pharmaceutical Sub-Sector Manufacturing Companies

Factors Affecting Cash Holding in Pharmaceutical Sub-Sector Manufacturing Companies

The Effect of Raw Material Cost and Direct Labor Cost on Selling Prices in Manufacturing Companies in the Consumer Goods Industry Sector of the Pharmaceutical Sub-Sector Listed on the Indonesia Stock Exchange

Covid 19 is a phenomenon that occurs in the world, especially Indonesia, in dealing with this phenomenon, of course the health sector is at the forefront of dealing with Covid 19, especially in the pharmaceutical sector which provides various types of drugs. With the large demand and scarcity of medicines and supplements to maintain immunity to avoid the spread of Covid 19, the raw materials for medicines have experienced a significant increase in prices. The Effect of Raw Material Costs and Direct Labor Costs on Selling Prices in Manufacturing Companies in the Consumer Goods Industrial Sector in the Pharmaceutical Sub-Sector Listed on the Indonesia Stock Exchange (IDX) is a research project the authors are interested in undertaking based on the phenomena that they observe. both individually or simultaneously. The research carried out is quantitative research with the hypothesis used, namely the two-party test. The analytical technique used is the Normality Test, Product Moment Correlation Test, Multiple Correlation Test, Multiple Linear Regression Test, Coefficient of Determination, T Test, F Test. Statistical calculations using SPSS Version 26.

Pengaruh Cash Ratio, Return on Equity, Debt to Equity Ratio, dan Ukuran Perusahaan terhadap Nilai Perusahaan

This study aims to determine the effect of Casb Ratio, Return On Equity, Debt to Equity Ratio, and Company Size on Company Value in the pharmaceutical sub-sector listed on the Indonesia Stock Exchange for the period 2018 – 2022. The sample for this study were 8 companies in the pharmaceutical sub-sector that were registered on the Indonesia Stock Exchange for the 2018-2022 period. This research was conducted using the panel data regression method assisted by the Eviews 10 program and Microsoft Excel 2016. The results showed that Cash Ratio, Return On Equity, and Firm Size partially had no significant effect on Firm Value. Meanwhile, the Debt to Equity Ratio has an effect on Firm Value.

Pengaruh Biaya Produksi dan Biaya Operasional Terhadap Laba Bersih pada Perusahaan Manufaktur Sub Sektor Farmasi yang Terdaftar di Bursa Efek Indonesia (BEI) Periode 2016-2020

This study was conducted to examine the effect of production costs and operating costs on the net profit of manufacturing companies in the Pharmaceutical Sub-Sector listed on the IDX for the 2016-2020 period. The research sample consists of 7 pharmaceutical sub-sector companies listed on the IDX. Meanwhile, there are 35 total observational data determined by purposive sampling. Annual report data obtained by indo-exchange file (IDX). The technique in collecting data is through documentation. Then the technique for analyzing the data in this study is multiple linear regression using SPSS 25. The study found that production costs showed a significant effect on net income. Likewise, operating costs show a significant effect on net income. Meanwhile, it was simultaneously found that production costs and operating costs significantly affected net income.

Influence of Total Assets and Sales Volume Through Net Profit on Stock Prices in the Pharmaceutical Sub-Sector Listed on the Indonesian Stock Exchange Period 2016-2022

Influence of Total Assets and Sales Volume Through Net Profit on Stock Prices in the Pharmaceutical Sub-Sector Listed on the Indonesian Stock Exchange Period 2016-2022

The Influence of Capital Structure and Profitability on Firm Value in The Pharmaceutical Sub-Sector for The Period 2017-2021

Firm value is the consequence of a company's performance, as represented in its share price, which is determined by the relationship between supply and demand in the stock market. The aim is to test and assess the impact of capital structure (DER) and profitability (ROA) on Firm value (PBV) in pharmaceutical firms listed on the Indonesia Stock Exchange (BEI) between 2017 and 2021. Purposive sampling is used to establish sampling. Ten pharmaceutical businesses serve as the research population. During a 5-year observation period, 40 samples were chosen from 8 firms based on the specified criteria. The analytical approach used in this study is multiple linear regression. The data analysis test tool runs the IBM SPSS version 26.0 program on Windows. The findings of this study reveal that capital structure has a significant influence (sig. 0.000) on firm value as well as profitability (sig. 0.022).

The Effect of Capital Structure and Profitability on Company Value in Pharmaceutical Sub-Sector Manufacturing Companies Listed in the Indonesia Stock Exchange

The Impact of Capital Structure and Profitability on Company Value in Pharmaceutical Sub-Sector Manufacturing Companies Listed on the Indonesian Stock Exchange. (Supervised by H. Abdul Rahman Mus and Junaiddin Zakaria). This study aimed to rigorously examine the effect of capital structure and profitability on company value in pharmaceutical sub-sector manufacturing companies listed on the Indonesia Stock Exchange.This study employed a quantitative approach using secondary data. This study was conducted on representatives of the Indonesian Stock Exchange in the Indonesian Stock Exchange Gallery located at the Faculty of Economics and Business, Universitas Muslim Indonesia, JL Urip Sumoharjo KM. 5 Makassar, South Sulawesi. The study was carried out from November to December 2023, for around two months. The population in this study were pharmaceutical sub-sector companies listed on the Indonesian Stock Exchange in 2019-2022, for a total of 11 companies. Applying a purposive sampling technique, a number of predetermined criteria resulted in eight pharmaceutical sub-sector companies as samples. The data were analyzed using the Statistical Program for Social Science (SPSS) with multiple linear analysis techniques and classical assumption tests. The results of this study reported that: (1) capital structure demonstrated a positive and significant effect on company value; (2) profitability illustrated a positive and insignificant effect on company value.

PENGARUH CASH RATIO, DEBT TO EQUITY RATIO, TOTAL ASSET TURN OVER DAN PERTUMBUHAN PENJUALAN TERHADAP RETUREN ON EQUITY (Studi Empiris Pada Perusahaan Sub Sektor Farmasi Yang Terdaftar Di Bursa Efek Indonesia Periode 2018-2022)

This study aims to analyze Cash Ratio, Debt to Equity Ratio, Total Asset Turn Over and Sales Growth on Return On Equity in Pharmaceutical Sub-Sector Companies Listed on the Indonesia Stock Exchange for the period 2018-2022. This research is a quantitative study using purpose sampling technique in determining the sample, and obtained 11 companies from 12 companies. The analysis model used in this research is multiple linear regression models. The results of this study indicate that Cash Ratio, Debt to Equity Ratio, and Total Asset Turn Over have a significant effect on Return On Equity, while Sales Growth has no effect on Return On Equity.

Pengaruh Financial Leverage, Kebijakan Dividen, Profitabilitas, Ukuran Perusahaan Dan Likuiditas Terhadap Nilai Perusahaan Pada Perusahaan Farmasi Yang Terdaftar Di Bursa Efek Indonesia Pada Tahun 2015-2019

This study aims to examine and determine the effect of financial leverage, dividend policy, profitability, firm size, and liquidity on firm value in pharmaceutical sub-sector companies listed on the Indonesia Stock Exchange. The population in this study were all pharmaceutical companies listed on the Indonesia Stock Exchange in 2015-2019. The sampling technique utilized the purposive sampling method and obtained 7 companies. This study utilized multiple regression analysis. The results show that partially financial leverage and profitability variables have an effect on firm value, meanwhile dividend policy, firm size and liquidity variables don’t have effect on firm value. Simultaneously the variables of financial leverage, dividend policy, profitability, firm size and liquidity have an effect on firm value. This research is expected to provide benefits for the pharmaceutical sub-sector.

The Influence of Company Size, Profitability, Liquidity, And Leverage On Firm Value In Pharmaceutical Sub-Sector Manufacturing Companies Listed On The Indonesian Stock Exchange For The Period 2012-2015

This study aims to analyze the effect of company size, profitability, liquidity and leverage on firm value in pharmaceutical sub-sector manufacturing companies listed on the Indonesia Stock Exchange for the period 2012-2015. This research was conducted by taking a sample of 7 pharmaceutical companies. Samples were taken from the financial statements for each year during 2012-2015. The method used is Multiple Linear Regression Analysis and data testing is carried out with SPSS (Statistical Product and Service Solution) 23 program. The test results show that the overall percentage of company size, profitability, liquidity and leverage on firm value is 74.6% while the rest is explained by other variables not included in this study. The results showed that company size has a positive and significant effect on firm value, profitability has a negative and weakly significant effect on firm value, liquidity has a negative and significant effect on firm value, leverage has a negative and significant effect on Company Value. Suggestions that can be given are that future research by adding a longer time span and using a larger and wider sample to obtain consistency in research results.

PENGARUH PENGUNGKAPAN AKUNTANSI LINGKUNGAN DAN CSR TERHADAP KINERJA KEUANGAN PERUSAHAAN SUBSEKTOR FARMASI DI BURSA EFEK INDONESIA TAHUN 2018-2021

This research aims to determine the effect of environmental accounting and corporate social responsibility disclosures on the financial performance of pharmaceutical sub-sector manufacturing companies listed on the Indonesia Stock Exchange in 2018-2021. Environmental accounting disclosures will encourage the ability to minimize environmental problems faced by the Company, problems of environmental damage, their causes and their impact on human life both now and in the future. This encourages people to realize the importance of environmental conservation. This research uses quantitative methods. The sample in this research was 36 data collection using the company's annual report. Sampling used total sampling and the significance level used was 0.05. Based on research results, Environmental Accounting positively and significantly influences financial performance, Corporate Social Responsibility positively and significantly influences financial performance, Environmental Accounting disclosure and Corporate Social Responsibility simultaneously influence the financial performance of Pharmaceutical Sub-Sector Manufacturing Companies Listed on the Stock Exchange Indonesia in 2018-2021.

Analysis of Profitability Ratios on Market Perception of Pharmaceutical Sub-Sector Companies (2017-2022)

Objective :This study was conducted to determine the difference between NPM, ROA and Stock Price before and after the pandemic, as well as to find out how the influence of NPM and ROA on market perception in pharmaceutical sub-sector companies for the period 2017 - 2022. Design/Methods/Approach : The data collection method uses secondary data from the company's financial statements. Purposive sampling was used for sampling in the study which made eight companies as objects. T-test and linear regression analysis are the techniques for analyzing this data. Findings :The t-test research results show that there is no difference between NPM, ROA, and Market Perception before and after the pandemic. This can be caused by erratic market behavior. The T test and F test show that NPM and ROA partially and simultaneously have no significant effect on market perception. Originality/Value: Market perception in pharmaceutical sub-sector companies for the period 2017 - 2022. The T test and F test With SPSS Practical/Policy implication : In this case, market perception is not only influenced by financial performance, especially profitability, but is influenced by many other factors

Effect of Cash Turnover, Receivables Turnover and Inventory Turnover on The Profitability of Pharmaceutical

The business run by the company aims to create the highest possible profit, this profit is expected to continue to be generated in the short and long term. Investment is very necessary in achieving maximum profit. The investment consists of working capital such as: Cash, Accounts Receivable, and Inventory. In increasing profitability, it is followed by cash turnover, receivables turnover and inventory turnover which can rotate effectively every period. This study aims to examine the effect of Cash Turnover, Receivable Turnover and Inventory Turnover on the profitability of the Pharmaceutical Sub-sector companies listed on the Indonesia Stock Exchange. The sampling technique used in this study was purposive sampling method. The analysis model of this research is Multiple Linear Regression Analysis. The results of the study partially show that Cash Turnover, Accounts Receivable Turnover and Inventory Turnover have no significant effect on the profitability of the pharmaceutical sub-sector companies listed on the Indonesia Stock Exchange. Simultaneous research results show that cash turnover, accounts receivable turnover, and inventory turnover have no significant effect on the profitability of pharmaceutical sub-sector companies listed on the Indonesia Stock Exchange.
 Keyword: Cash Turnover, Inventory Turnover, Profitability, Receivable Turnover

Analisis Kinerja Keuangan pada Sub Sektor Farmasi yang Terdaftar di Bursa Efek Indonesia Menggunakan Metode Economic Value Added dan Market Value Added

The pharmaceutical industry experienced growth from 2019 to 2021, driven by increased demand for medicines. However, in 2022, the growth of the pharmaceutical industry slowed down due to the impact of the Covid-19 pandemic in Indonesia. This research aims to describe the financial performance conditions of pharmaceutical sub-sector companies, measured using the Economic Value Added (EVA) and Market Value Added (MVA) methods. The research method used is a quantitative method with a descriptive approach. The type of data used is secondary data obtained from the website www.idx.co.id. The sample selection was carried out using purposive sampling technique, resulting in a total of 10 pharmaceutical sub-sector companies listed on the Indonesia Stock Exchange (BEI) during the period from 2019 to 2022. The results of the financial performance analysis of companies using the EVA method indicate that pharmaceutical sub-sector companies have a good performance as they were able to generate a positive Economic Value Added (EVA > 0), signifying that the companies generated profits greater than the cost of capital, thus indicating good financial performance. Meanwhile, the financial performance analysis using the MVA method shows that pharmaceutical sub-sector companies were able to produce a positive Market Value Added (MVA > 0), indicating that the performance of the pharmaceutical sub-sector is in a good condition as the market value of the companies experienced an increase that exceeds the total capital invested by shareholders.